DETROIT, MI
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)BARBARA ANN KARMANOS CANCER HOSPITAL, founded in 2004, is a major nonprofit in the Diseases & Disorders sector that reported $572.6M in total revenue in fiscal year 2023. Revenue surged 22% from the prior year, signaling strong growth momentum. Expenses of $509.4M left a modest 11% surplus.
THE BARBARA ANN KARMANOS CANCER HOSPITAL IS DEDICATED TO THE DELIVERY OF CANCER CARE SERVICES, THE TREATMENT AND CARE OF CANCER PATIENTS AND THE PREVENTION OF CANCER. ADDITIONALLY, KARMANOS PROMOTES, ENCOURAGES, AIDS AND PERFORMS SCIENTIFIC INVESTIGATIONS AND RESEARCH ADDRESSING THE CAUSE, TREATMENT AND PREVENTION OF CANCER. ESSENTIAL CANCER MEDICAL SERVICES ARE PROVIDED TO THE COMMUNITY.
INPATIENT: HEALTH CARE DELIVERY & MANAGEMENT: BARBARA ANN KARMANOS CANCER HOSPITAL IS DEDICATED TO THE DELIVERY OF CANCER CARE SERVICES, THE TREATMENT AND CARE OF CANCER PATIENTS AND THE PREVENTION...
INPATIENT: HEALTH CARE DELIVERY & MANAGEMENT: BARBARA ANN KARMANOS CANCER HOSPITAL IS DEDICATED TO THE DELIVERY OF CANCER CARE SERVICES, THE TREATMENT AND CARE OF CANCER PATIENTS AND THE PREVENTION OF CANCER. ADDITIONALLY, KARMANOS PROMOTES, ENCOURAGES, AIDS AND PERFORMS SCIENTIFIC INVESTIGATIONS AND RESEARCH ADDRESSING THE CAUSE, TREATMENT AND PREVENTION OF CANCER. ESSENTIAL CANCER MEDICAL SERVICES ARE PROVIDED TO THE COMMUNITY. FROM OCTOBER 2023 TO SEPTEMBER 2024, KARMANOS HAD 20,476 PATIENT DAYS AND 2,248 DISCHARGES FOR AN AVERAGE LENGTH OF STAY OF 9.11 DAYS. IN ADDITION, THERE WERE 227 BONE MARROW TRANSPLANTS, 999 INPATIENT SURGERIES, AND 6,930 INPATIENT IMAGING ENCOUNTERS.
AMBULATORY SERVICES: THE BARBARA ANN KARMANOS CANCER HOSPITAL PROVIDED MEDICAL SERVICES TO CANCER PATIENTS INCLUDING RADIATION ONCOLOGY, CHEMOTHERAPY, BONE MARROW TRANSPLANT, MAMMOGRAPHY AND...
AMBULATORY SERVICES: THE BARBARA ANN KARMANOS CANCER HOSPITAL PROVIDED MEDICAL SERVICES TO CANCER PATIENTS INCLUDING RADIATION ONCOLOGY, CHEMOTHERAPY, BONE MARROW TRANSPLANT, MAMMOGRAPHY AND HEMATOLOGY CONSULTATIVE, DIAGNOSTIC AND TREATMENT SERVICES. ESSENTIAL CANCER AND MEDICAL SERVICES ARE PROVIDED TO THE COMMUNITY. FROM OCTOBER 2023 TO SEPTEMBER 2024, THE FOLLOWING OUTPATIENT STATISTICS WERE REPORTED: CLINICAL ENCOUNTERS 61,946; INFUSION PATIENT ENCOUNTERS 27,722; IMAGING ENCOUNTERS 43,984; PHERESIS PATIENT ENCOUNTERS 536; INPATIENT AND OUTPATIENT RADIATION ONCOLOGY ENCOUNTERS 25,155 AND OUTPATIENT SURGIERIES 1,552.
THE BARBARA ANN KARMANOS CANCER HOSPITAL PROMOTES AIDS AND PERFORMS SCIENTIFIC INVESTIGATIONS AND RESEARCH ADDRESSING THE CAUSE, TREATMENTS AND PREVENTION OF CANCER. FOR THE PERIOD OCTOBER 2023 TO...
THE BARBARA ANN KARMANOS CANCER HOSPITAL PROMOTES AIDS AND PERFORMS SCIENTIFIC INVESTIGATIONS AND RESEARCH ADDRESSING THE CAUSE, TREATMENTS AND PREVENTION OF CANCER. FOR THE PERIOD OCTOBER 2023 TO SEPTEMBER 30, 2024, KCC HAD 4,668 PHASE 1 INFUSION PATIENT VISITS, 275 ACTIVE CLINICAL DRUG TRIALS; 305 PATIENTS WILLING TO PARTICIPATE IN CLINICAL PROGRAMS, AND 465 ELIGIBLE AND REGISTERED PARTICIPANTS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $572,612,251 | $468,910,123 | +0.2% |
| Expenses | $509,449,475 | $434,686,052 | +0.2% |
| Net Income | $63,162,776 | $34,224,071 | +0.8% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| PHILIP INCARNATI | BOARD MEMBER | 1.00 |
Director
|
$0 | $48,318 | $11,859,773 |
| SYED RAZA | PHYSICIAN MANAGER | 40.00 |
Highest
|
$1,028,084 | $16,514 | $1,044,598 |
| JEFFREY HOTALING | PHYSICIAN MANAGER | 40.00 |
Highest
|
$990,265 | $16,514 | $1,006,779 |
| BRIAN GAMBLE | PRESIDENT KCC | 41.00 |
Officer
Director
|
$0 | $38,067 | $797,334 |
| NATASHA ROBINETTE | SERVICE CHIEF RADIOLOGY | 40.00 |
Highest
|
$688,308 | $16,514 | $704,822 |
| DAVID STERNBERG | PHYSICIAN MANAGER | 40.00 |
Highest
|
$617,581 | $30,042 | $647,623 |
| HUSSEIN AOUN | RADIOLOGIST | 40.00 |
Highest
|
$599,350 | $43,324 | $642,674 |
| REGINA DOXTADER | VP CFO & SECRETARY | 21.00 |
Officer
|
$0 | $23,984 | $363,806 |
| CHRISTOPHER D GRAUNSTADT | VP, OPERATIONS | 40.00 |
Key Emp
|
$310,601 | $35,566 | $346,167 |
| KATHLEEN CAROLIN | VP, CHIEF NURSING OFFICER | 40.00 |
Key Emp
|
$296,892 | $21,100 | $317,992 |
| JACOB BURMEISTER | CHIEF OF PHYSICS | 40.00 |
Key Emp
|
$287,452 | $12,949 | $300,401 |
| STEPHEN SMITH | VP CHIEF PHARMACY OFFICER | 40.00 |
Key Emp
|
$259,781 | $11,305 | $271,086 |
| BORIS PASCHE MD | BOARD MEMBER/PRESIDENT KCI | 1.00 |
Officer
Director
|
$0 | $2,048 | $248,833 |
| GEORGE H YOO MD | CHIEF MEDICAL OFFICER | 41.00 |
Officer
Director
|
$182,980 | $0 | $182,980 |
| TIMOTHY MONAHAN | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $36,000 |
| SCOTT HUNTER | BOARD MEMBER/CHAIR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| JIM BENNETHUM | BOARD MEMBER - PART YEAR | 1.00 |
Director
|
$0 | $0 | $0 |
| KAREN CULLEN | BOARD MEMBER - PART YEAR | 1.00 |
Director
|
$0 | $0 | $0 |
| GEANEEN M ARENDS | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| SHARI FERBER-KAUFMAN | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| SYLVESTER HESTER | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| MICHAEL DUHAIME | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| MYRON FRASIER | BOARD MEMBER - PART YEAR | 1.00 |
Director
|
$0 | $0 | $0 |
| TOM KALAS | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| DANIEL RET | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| DAVID E DUPREY | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| KIMBERLY ESPY | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| ABHINAV DEOL MD | BOARD MEMBER - PART YEAR | 1.00 |
Director
|
$0 | $0 | $0 |
| WAEL SAKR | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $572,612,251 | $509,449,475 | $237,115,927 | $63,162,776 |
| 2023 | $468,910,123 | $434,686,052 | $268,756,956 | $34,224,071 |
| 2023 | $468,910,123 | $434,686,052 | $268,756,956 | $34,224,071 |
| 2022 | $402,469,972 | $377,588,451 | $204,595,141 | $24,881,521 |
| 2021 | $374,893,071 | $354,322,783 | $299,240,270 | $20,570,288 |
| 2020 | $324,568,138 | $304,003,178 | $267,671,466 | $20,564,960 |
| 2019 | $304,637,537 | $288,041,032 | $225,571,437 | $16,596,505 |
| 2018 | $279,850,206 | $267,682,164 | $199,390,031 | $12,168,042 |
Compare BARBARA ANN KARMANOS CANCER HOSPITAL with other nonprofits in Michigan and across the country.